Glycopyrrolate
Glycopyrrolate is an anticholinergic medication available as an injectable solution (0.2 mg/mL) for intramuscular or intravenous administration. It works by blocking certain nerve signals to reduce secretions and treat conditions like excessive salivation or slow heart rate. Marketed as a prescription drug under ANDA211334 by Sandoz. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Glycopyrrolate is an anticholinergic medication available as an injectable solution (0.2 mg/mL) for intramuscular or intravenous administration. It works by blocking certain nerve signals to reduce secretions and treat conditions like excessive salivation or slow heart rate. Marketed as a prescription drug under ANDA211334 by Sandoz. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Glycopyrrolate", "mediaType": "text/html", "description": " Access the FDA dataset for Glycopyrrolate — ANDA 211705 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211705" } ] |
| identifier | ANDA211705 |
| issued | 2016-09-16 |
| keyword |
[ "drug-information", "health-care", "pharmaceuticals", "prescription-drugs", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Glycopyrrolate |
